MF

Michael Freeman Raymond James Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
4
Avg Return
Past Year
36%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 100%
Neutral 0%
Negative 0%
Stock Rating Price Target Upside
Downside 		Ratings
1 Year 		Avg Return
1 Year 		Success Rate
1 Year 		Date
Outperform Assumed
$14
95%
upside
1 +73%
0 %
11 Jun ‘25 10 months ago
Outperform Reinstated
$76
166%
upside
1 +31%
0 %
11 Jun ‘25 10 months ago
Outperform Assumed
$37
103%
upside
1 +25%
0 %
11 Jun ‘25 10 months ago
Strong Buy Reinstated
$89
29%
upside
1 +15%
0 %
11 Jun ‘25 10 months ago
Strong Buy Initiated
$65
11%
downside
1 +117%
0 %
11 Jun ‘25 10 months ago